Status:
COMPLETED
Diuretics and Angiotensin-Receptor Blocker Agents in Patients With Stage I Hypertension
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Collaborating Sponsors:
Financiadora de Estudos e Projetos
Conditions:
Hypertension
Cardiovascular Disease
Eligibility:
All Genders
40+ years
Phase:
PHASE3
Brief Summary
High blood pressure is the major risk factor for Cardiovascular disease (CVD). The prevalence of hypertension in Brazil was established in population-based studies conducted in different cities and St...
Detailed Description
Cardiovascular disease (CVD) is already the leading cause of death in Brazil. The superiority of any particular agent among the groups of blood pressure-lowering drugs was investigated in various clin...
Eligibility Criteria
Inclusion
- patients older than 40 years of age with stage I hypertension
Exclusion
- low life expectancy
- other indications for the use of diuretics, such as cardiovascular disease
- intolerance to the study drugs
- pregnancy
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
655 Patients enrolled
Trial Details
Trial ID
NCT00971165
Start Date
July 1 2010
End Date
September 1 2014
Last Update
February 12 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Clínicas de Porto Alegre, UFRGS
Porto Alegre, Rio Grande do Sul, Brazil, 90035 903
2
Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil, 90035-903